Asian Pacific Journal of Cancer Prevention

  • 제13권11호
  • /
  • Pages.5691-5694
  • /
  • 2012
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

No Association between the CDX2 G543C Polymorphism and Risk of Gastric Atrophy and Cancer

  • Goto, Yasuyuki (Department of Preventive Medicine, Nagoya University Graduate School of Medicine) ;
  • Kato, Tsuyoshi (Department of Gastroenterology, Nagoya University Graduate School of Medicine) ;
  • Ando, Takafumi (Department of Gastroenterology, Nagoya University Graduate School of Medicine) ;
  • Goto, Hidemi (Department of Gastroenterology, Nagoya University Graduate School of Medicine) ;
  • Hamajima, Nobuyuki (Department of Preventive Medicine, Nagoya University Graduate School of Medicine)
  • 발행 : 2012.11.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Ectopic expression of CDX2 in the stomach is closely associated with chronic Helicobacter pylori (H. pylori) infection and intestinal metaplasia. Whether CDX2 has tumor suppression or tumorigenesis potential remains to be elucidated. In this study, we investigated the association between the CDX2 G543C polymorphism (silent mutation) and the risk for H. pylori-induced gastric atrophy and cancer as well as H. pylori infection, using 454 Japanese subjects undergoing a health checkup and 202 gastric cancer patients. The frequency of the minor allele was the same as previously reported in China, but different from that reported in England. CDX2 G543C was not associated with risk of H. pylori infection, gastric atrophy, or gastric cancer, although the point estimate for non-cardiac differentiated gastric cancer as compared to controls with gastric atrophy was 2.22 (95%CI=0.17-29.4). In conclusion, our results indicate that the CDX2 G543C polymorphism is unlikely to affect the H. pylori infection-gastric atrophy-gastric cancer sequence.

키워드

참고문헌

  1. Almeida R, Silva E, Santos-Silva F, et al (2003). Expression of intestine-specific transcription factors, CDX1 and CDX2, in intestinal metaplasia and gastric carcinomas. J Pathol, 199, 36-40. https://doi.org/10.1002/path.1246
  2. Asaka M, Takeda H, Sugiyama T, et al (1997). What role does Helicobacter pylori play in gastric cancer? Gastroenterol, 113, 56-60. https://doi.org/10.1016/S0016-5085(97)80013-3
  3. Asaka M, Sugiyama T, Nobuta A, et al (2001). Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study. Helicobacter, 6, 294-9. https://doi.org/10.1046/j.1523-5378.2001.00042.x
  4. Bai YQ, Yamamoto H, Akiyama Y, et al (2002). Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach. Cancer Lett, 8, 47-55.
  5. Barros R, da Costa LT, Pinto-de-Sousa J, et al (2011). CDX2 autoregulation in human intestinal metaplasia of the stomach: impact on the stability of the phenotype. Gut, 60, 290-8. https://doi.org/10.1136/gut.2010.222323
  6. Blaser MJ, Perez-Perez GI, Kleanthous H, et al (1995). Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res, 55, 2111-5.
  7. Bonhomme C, Duluc I, Martin E, et al (2003) The Cdx2 homeobox gene has a tumour suppressor function in the distal colon in addition to a homeotic role during gut development. Gut, 52, 1465-71. https://doi.org/10.1136/gut.52.10.1465
  8. Borch K, Axelsson CK, Halgreen H, et al (1989). The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. Scand J Gastroenterol, 24, 870-6. https://doi.org/10.3109/00365528909089228
  9. Correa P, Haenszel W, Cuello C, et al (1975). A model for gastric cancer epidemiology. Lancet, 12, 58-60.
  10. Correa P, Piazuelo MB (2008). Natural history of Helicobacter pylori infection. Dig Liver Dis, 40, 490-6. https://doi.org/10.1016/j.dld.2008.02.035
  11. Dinis-Ribeiro M, Yamaki G, Miki K, et al (2004). Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen, 11, 141-7. https://doi.org/10.1258/0969141041732184
  12. Duluc I, Lorentz O, Fritsch C, et al (1997). Changing intestinal connective tissue interactions alters homeobox gene expression in epithelial cells. J Cell Sci, 110, 1317-24.
  13. Eda A, Osawa H, Yanaka I, et al (2002). Expression of homeobox gene CDX2 precedes that of CDX1 during the progression of intestinal metaplasia. J Gastroenterol, 37, 94-100. https://doi.org/10.1007/s005350200002
  14. Gehring WJ, Muller M, Affolter M, et al (1990). The structure of the homeodomain and its functional implications. Trends Genet, 6, 323-9. https://doi.org/10.1016/0168-9525(90)90253-3
  15. Goto Y, Ando T, Yamamoto K, et al (2006). Association between serum pepsinogens and polymorphismof PTPN11 encoding SHP-2 among Helicobacter pylori seropositive Japanese. Int J Cancer, 118, 203-8. https://doi.org/10.1002/ijc.21338
  16. Kang JM, Lee BH, Kim N, et al (2011). CDX1 and CDX2 expression in intestinal metaplasia, dysplasia and gastric cancer. J Korean Med Sci, 26, 647-53. https://doi.org/10.3346/jkms.2011.26.5.647
  17. Kekki M, Samloff IM, Varis K, et al (1991). Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol, 186, 109-16.
  18. Lambert JR, Lin SK, Aranda-Michel J (1995). Helicobacter pylori. Scand J Gastroenterol, 208, 33-46.
  19. Lauren P (1965). The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at histo-clinical calsification. Acta Pathol Microbiol Scand, 64, 31-49. https://doi.org/10.1111/apm.1965.64.1.31
  20. Lorentz O, Duluc I, Arcangelis AD, et al (1997). Key role of the Cdx2 homeobox gene in extracellular matrix-mediated intestinal cell differentiation. J Cell Biol, 15, 1553-65.
  21. Mallo GV, Rechreche H, Frigerio JM, et al (1997). Molecular cloning, sequencing and expression of the mRNA encoding human Cdx1 and Cdx2 homeobox. Down-regulation of Cdx1 and Cdx2 mRNA expression during colorectal carcinogenesis. Int J Cancer, 74, 35-44. https://doi.org/10.1002/(SICI)1097-0215(19970220)74:1<35::AID-IJC7>3.0.CO;2-1
  22. Mutoh H, Sakurai S, Satoh K, et al (2004). Development of gastric carcinoma from intestinal metaplasia in Cdx2-transgenic mice. Cancer Res, 64, 7740-7. https://doi.org/10.1158/0008-5472.CAN-04-1617
  23. Nakamura K, Sugano H, Takagi K (1968). Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. Gann, 59, 251-8
  24. Qin R, Wang NN, Chu J, et al (2012). Expression and significance of homeodomain protein Cdx2 in gastric carcinoma and precancerous lesions. World J Gastroenterol, 18, 3296-302.
  25. Satoh K, Mutoh H, Eda A, et al (2002). Aberrant expression of CDX2 in the gastric mucosa with and without intestinal metaplasia: effect of eradication of Helicobacter pylori. Helicobacter, 7, 192-8. https://doi.org/10.1046/j.1523-5378.2002.00080.x
  26. Sivagnanasundaram S, Islam I, Talbot I, et al (2001). The homeobox gene CDX2 in colorectal carcinoma: a genetic analysis. Br J Cancer, 84, 218-25. https://doi.org/10.1054/bjoc.2000.1544
  27. Wang XT, Xie YB, Xiao Q (2012). siRNA targeting of Cdx2 inhibits growth of human gastric cancer MGC-803 cells. World J Gastroenterol, 18, 1903-14. https://doi.org/10.3748/wjg.v18.i16.1903
  28. Xia X, Xu E, Quan S, et al (2009). No association between the polymorphisms in CDX2 coding regions and colorectal cancer in Chinese. Mol Cell Biochem, 331, 27-30. https://doi.org/10.1007/s11010-009-0141-2
  29. Xie Y, Li L, Wang X, et al (2010). Overexpression of Cdx2 inhibits progression of gastric cancer in vitro. Int J Oncol, 36, 509-16.
  30. Yagi OK, Akiyama Y, Yuasa Y (1999). Genomic structure and alterations of homeobox gene CDX2 in colorectal carcinomas. Br J Cancer, 79, 440-4. https://doi.org/10.1038/sj.bjc.6690068